JavaScript is disabled. Please enable to continue!

Mobile search icon
Method Development >> Characterization >> Solid State Characterization

Solid State Characterization

Sidebar Image

Solid State CharacterizationEurofins BioPharma Product Testing's network of laboratories can support solid-state characterization by offering method development and testing services on raw materials, active pharmaceutical ingredients (API), and pharmaceutical drug products through X-ray Powder Diffraction (XRPD), as well as Solid-State NMR (ssNMR).

Why Choose Eurofins BioPharma Product Testing?

  • All methods and testing are performed under GMP requirements and are FDA inspected.
  • Our state-of-the-art equipment allows high capacity, optimum sensitivity and fast turn-aroundtime, supporting development and product release.
  • Our broad scope of NMR capabilities and knowledge are centralized in the European Centre of Excellence for NMR in Oss, the Netherlands.

Solid-state NMR including 19F-NMR capabilities

We are one of few laboratories in the world that can provide ssNMR method development and testing services on ingredients, polymers and pharmaceutical drug substances and products with 19F-NMR application under GMP guidelines.

Solutions and Applications

  • Identification and quantitation of polymorphs in APIs
  • Identification and quantitation of polymorphs of APIs in dosage forms (depending on the drug loading)
  • Evaluation of crystalline and amorphous ratio for APIs
  • Spectroscopic confirmation of identity
  • Characterization of polymers
  • Patent infringement assessment

Equipment

400MHz WB Bruker Avance 

  • Our system is fitted with a dedicated 19F-NMR setup allowing 1H-19F CPMAS experiment
  • 10 positions sample changer
  • Probes: 4mm MAS (1H, 19F, X), 7mm MAS (1H, X)

XRPD characterization and testing

We provide XRPD (X-ray Powder Diffraction) method development and testing services on raw materials, API and pharmaceutical drug products, under GMP guidelines.

Solutions and Applications

  • Identification and quantitation of polymorphs in APIs
  • Identification of API in Dosage Forms (depending on the drug loading)
  • Quantitation of crystalline and amorphous ratio for APIs and excipients, depending on the individual composition
  • Crystallographic confirmation of identity
  • Rietveld Analysis to refine atomic structures and the composition of multiphase mixtures
  • XRDP phase analysis and pattern decomposition

Equipment

Empyrean Panalytical

  • System can measure both transmission and reflection geometry
  • 45 position sample changer
  • Fitted with a TTK (hotstage), which allows variable temperature experiments